CARPENTIER-EDWARDS SUPRANNULAR (S.A.V.) BIOPROSTHESIS MODEL 26506650

A Bioprosthetic Heart Valves Related Image

(Not Necessarily related to the device)

Description:

CARPENTIER-EDWARDS SUPRANNULAR (S.A.V.) BIOPROSTHESIS MODEL 26506650 by EDWARDS LIFESCIENCES LLC

The Carpentier-Edwards Suprannular (S.A.V) Bioprosthesis Model 26506650, presented by the renowned Edwards Lifesciences LLC, is expertly designed to enhance cardiovascular procedures by providing effective valve replacements.

This groundbreaking medical device is predominantly used for the replacement of damaged or non-functional heart valves, specifically in treatments related to aortic and mitral valve disease.

The highlight of the Model 26506650 lies in its bovine pericardial tissue design, offering distinct advantages over traditional synthetic materials. Carefully treated, this organic material facilitates excellent biocompatibility and enhanced durability, hence, it is less prone to thrombosis, reducing the likelihood or necessity of concurrent anticoagulation treatment.

Designed to fulfill the complex requirements of sensitive cardiovascular surgeries, the Model 26506650 features a suprannular design that seeks to optimize the hemodynamic performance and therefore, offers improved patient outcomes.

In sum, the Carpentier-Edwards Suprannular (S.A.V) Bioprosthesis Model 26506650 provides an optimal balance of performance, durability, and biocompatibility; acting as a significant advancement in heart valve replacement technology, it exhibits not only Edwards Lifesciences LLC's deep commitment to life-saving innovation but also their dedication to improving patient wellbeing and their quality of life.

Primary Use:

Carpentier-Edwards Suprannular (S.A.V.) Bioprosthesis Model 26506650

Primary Use: The Carpentier-Edwards Suprannular (S.A.V.) Bioprosthesis Model 26506650 is a sophisticated device employed widely in the realm of cardiac surgery. This device has been purposefully designed to replace damaged or dysfunctional native heart valves, primarily the aortic valve.
In essence, it serves as a mechanical surrogate to ensure the unimpeded, unidirectional flow of blood from the heart to the rest of the body. Given its bioprosthetic nature, the valve used in the Carpentier-Edwards Suprannular Bioprosthesis is derived from animal heart valves, typically porcine. These valves are processed meticulously to assure durability and performance that can closely mimic human heart valves

How It Works:

Understanding the Mechanism of the Carpentier-Edwards Suprannular (S.A.V.) Bioprosthesis Model 26506650

The prestigious and innovative Carpentier-Edwards Suprannular (S.A.V.) Bioprosthesis Model 26506650 is a heart implant device that exemplifies medical advancement in the field of cardiac replacement therapies. This device, falling under the category of Heart Implants, is designed to replace diseased, damaged, or malfunctioning heart valves.

How the Carpentier-Edwards S.A.V. Bioprosthesis Operates

The Carpentier-Edwards S.A.V. Bioprosthesis imitates the functional mechanics of natural heart valves, particularly the aortic valve, by maintaining unidirectional blood flow from the heart to the body. Its design aims to emulate the native valve's hemodynamics, reducing turbulence and allowing efficient blood flow through the aorta. Biological Material: The bioprosthesis is principally composed of pericardial tissue, typically that of bovine, due to its excellent durability and biocompatibility. This pericardial tissue is treated with glutaraldehyde to structurally stabilize the tissue, minimizing antigenicity and ensuring longevity. Frame and Design: The bioprosthesis framework consists of a rigid, but light and biocompatible material - usually cobalt-chromium alloy, covered entirely by tissue to reduce the risk of blood clot formation. Its suprannular positioning supports enhanced blood flow characteristics, reducing obstructions and improving hemodynamics. Attachment Technique and Leaflet Design: The advanced Carpentier-Edwards ThermaFix process firmly secures the commissures to the frame with a three-dimensional sewing cuff, further reinforcing the device’s durability. The tri-leaflet design mimics the natural aortic valve, maintaining optimal blood flow with every heart contraction and relaxation cycle. The adequate deployment of the Carpentier-Edwards S.A.V. Bioprosthesis Model 26506650 re-establishes the regular physiological blood flow, reinforcing cardiac output and eventually ameliorating the clinical symptoms of the patient. With its outstanding design and reliability, this bioprosthesis is a prominent choice for cardiac valve replacement surgeries.

Conclusion

Indeed, the Carpentier-Edwards Suprannular (S.A.V.) Bioprosthesis Model 26506650 represents the vanguard of medical technology by enhancing patient outcomes through its design, material selection and improved hemodynamics. As medical professionals, our relentless endeavor is to provide exemplary care, and tools such as these undeniably aid us in achieving this mission.